UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Clinical utility of circulating DNA analysis for rapid detection of actionable mutations to select metastatic colorectal patients for anti-EGFR treatment

Annals of oncology, 2017-09, Vol.28 (9), p.2149-2159

2017

Volltextzugriff (PDF)

Sorafenib and irinotecan (NEXIRI) as second- or later-line treatment for patients with metastatic colorectal cancer and KRAS-mutated tumours: a multicentre Phase I/II trial

Breast cancer research and treatment, 2014-03, Vol.110 (5), p.1148-1154

2014

Volltextzugriff (PDF)

Triplet chemotherapy plus cetuximab as first-line treatment in RAS wild-type metastatic colorectal carcinoma patients

Annals of oncology, 2019-07, Vol.30, p.iv26-iv27

2019

Volltextzugriff (PDF)

A large-scale candidate gene approach identifies SNPs in SOD2 and IL13 as predictive markers of response to preoperative chemoradiation in rectal cancer

The pharmacogenomics journal, 2011-12, Vol.11 (6), p.437-443

2011

Volltextzugriff (PDF)

KRAS status analysis and anti-EGFR therapies: is comprehensiveness a biologist's fancy or a clinical necessity?

British journal of cancer, 2010-03, Vol.102 (6), p.1074-1075

2010

Volltextzugriff (PDF)

Functional categories of TP53 mutation in colorectal cancer: results of an International Collaborative Study

Annals of oncology, 2006-05, Vol.17 (5), p.842-847

2006

Volltextzugriff (PDF)

K-ras Mutation Detection by Hybridization to a Polypyrrole DNA Chip

Clinical chemistry (Baltimore, Md.), 2001-02, Vol.47 (2), p.186-194

2001

Volltextzugriff (PDF)

p53 status and response to radiotherapy in rectal cancer: a prospective multilevel analysis

British journal of cancer, 2005-06, Vol.92 (12), p.2114-2121

2005

Volltextzugriff (PDF)

Considerations for normalisation of RT-qPCR in oncology

Annales de biologie clinique (Paris), 2008-03, Vol.66 (2), p.121-129

2008

Volltextzugriff (PDF)

La RT-qPCR en oncologie : considérations pour la normalisation

Annales de biologie clinique (Paris), 2008-03, Vol.66 (2), p.121-129

2008

Volltextzugriff (PDF)

Abstract P5-06-08: BRCA1 promoter hypermethylation, but not BRCA1 expression, is associated with basal-like features and good prognosis in triple negative breast cancer

Cancer research (Chicago, Ill.), 2017-02, Vol.77 (4_Supplement), p.P5-P5-06-08

2017

Volltextzugriff (PDF)

P-099Triplet chemotherapy plus cetuximab as first-line treatment in RAS wild-type metastatic colorectal carcinoma patients

Annals of oncology, 2019-07, Vol.30 (Supplement_4)

2019

Volltextzugriff (PDF)

KRAS mutation detection in paired frozen and Formalin-Fixed Paraffin-Embedded (FFPE) colorectal cancer tissues

International journal of molecular sciences, 2011-05, Vol.12 (5), p.3191-3204

2011

Volltextzugriff (PDF)

A homogeneous europium cryptate-based assay for the diagnosis of mutations by time-resolved fluorescence resonance energy transfer

Nucleic acids research, 2001-07, Vol.29 (14), p.E70-70

2001

Volltextzugriff (PDF)

Abstract P3-05-06: Prognostic value of androgen receptor and FOXA1 co-expression in non-metastatic triple-negative breast cancer

Cancer research (Chicago, Ill.), 2017-02, Vol.77 (4_Supplement), p.P3-P3-05-06

2017

Volltextzugriff (PDF)

Abstract P2-02-05: Persistence of PIK3CA mutations detection in cell free tumor DNA as surrogate markers for hormonosensibility in patients with hormone receptor-positive breast cancer. The miRho clinical study

Cancer research (Chicago, Ill.), 2018-02, Vol.78 (4_Supplement), p.P2-P2-02-05

2018

Volltextzugriff (PDF)

1322 Diagnostic of KRAS gene mutations in colorectal cancer: evaluation of direct sequencing, pyrosequencing and allele specific amplification

European journal of cancer supplements, 2009, Vol.7 (2), p.145-145

2009

Volltextzugriff (PDF)

Biochips on CMOS: an active matrix address array for DNA analysis

Sensors and actuators. B, Chemical, 1999-12, Vol.61 (1-3), p.154-162

1999

Volltextzugriff (PDF)

Sorafenib (Soraf) and irinotecan (Iri) combination for pretreated RAS-mutated metastatic colorectal cancer (mCRC) patients: a multicentre randomized phase II trial (NEXIRI 2-PRODIGE 27)

Annals of oncology, 2016-10, Vol.27, p.vi154-vi154

2016

Volltextzugriff (PDF)

Deregulation of the Cytoplasmic Tyrosine Kinase cSrc in the Absence of a Truncating Mutation at Codon 531 in Human Bladder Carcinoma

Biochemical and biophysical research communications, 2000-07, Vol.273 (2), p.425-430

2000

Volltextzugriff (PDF)

Prediction of Disease Outcome With Quantitative Measurement of HER-2 Receptor Expression and Dimerization in Patients With Breast Cancer

Annals of oncology, 2012-09, Vol.23, p.ix84

2012

Volltextzugriff (PDF)

KRAS mutation testing in patients with metastatic colorectal carcinoma: An 18-month experience emphasizing the risk of false-negative results

Journal of clinical oncology, 2010-05, Vol.28 (15_suppl), p.3572-3572

2010

Volltextzugriff (PDF)

Personalized Medicine by Analyzing Circulating DNA: Application to the Management Care of Colorectal Cancer Patients

Annals of oncology, 2013-03, Vol.24, p.i7-i7

2013

Volltextzugriff (PDF)

P3.12 Circulating Dna Analysis in The Era of Personalized Cancer Medicine: Application to Kras/Braf Point Mutations Detection in Colorectal Cancer

Annals of oncology, 2012-06, Vol.23, p.v36-v37

2012

Volltextzugriff (PDF)

Détection des mutations de KRAS : comparaison des résultats entre tissus fixés en formol/inclus en paraffine et tissus cryopréservés dans une série de 131 adénocarcinomes colorectaux

Annales de pathologie, 2011-11, Vol.31 (5), p.S143-S143

2011

Volltextzugriff (PDF)

1 – 25 von 71

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(55)
Mit Volltextzugriff
(66)

Publikationsform

Artikel
(71)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Clinical utility of circulating DNA analysis for rapid detection of actionable mutations to select metastatic colorectal patients for anti-EGFR treatment

Sorafenib and irinotecan (NEXIRI) as second- or later-line treatment for patients with metastatic colorectal cancer and KRAS-mutated tumours: a multicentre Phase I/II trial

Triplet chemotherapy plus cetuximab as first-line treatment in RAS wild-type metastatic colorectal carcinoma patients

A large-scale candidate gene approach identifies SNPs in SOD2 and IL13 as predictive markers of response to preoperative chemoradiation in rectal cancer

KRAS status analysis and anti-EGFR therapies: is comprehensiveness a biologist's fancy or a clinical necessity?

Functional categories of TP53 mutation in colorectal cancer: results of an International Collaborative Study

K-ras Mutation Detection by Hybridization to a Polypyrrole DNA Chip

p53 status and response to radiotherapy in rectal cancer: a prospective multilevel analysis

Considerations for normalisation of RT-qPCR in oncology

La RT-qPCR en oncologie : considérations pour la normalisation

Abstract P5-06-08: BRCA1 promoter hypermethylation, but not BRCA1 expression, is associated with basal-like features and good prognosis in triple negative breast cancer

P-099Triplet chemotherapy plus cetuximab as first-line treatment in RAS wild-type metastatic colorectal carcinoma patients

KRAS mutation detection in paired frozen and Formalin-Fixed Paraffin-Embedded (FFPE) colorectal cancer tissues

A homogeneous europium cryptate-based assay for the diagnosis of mutations by time-resolved fluorescence resonance energy transfer

Abstract P3-05-06: Prognostic value of androgen receptor and FOXA1 co-expression in non-metastatic triple-negative breast cancer

Abstract P2-02-05: Persistence of PIK3CA mutations detection in cell free tumor DNA as surrogate markers for hormonosensibility in patients with hormone receptor-positive breast cancer. The miRho clinical study

1322 Diagnostic of KRAS gene mutations in colorectal cancer: evaluation of direct sequencing, pyrosequencing and allele specific amplification

Biochips on CMOS: an active matrix address array for DNA analysis

Sorafenib (Soraf) and irinotecan (Iri) combination for pretreated RAS-mutated metastatic colorectal cancer (mCRC) patients: a multicentre randomized phase II trial (NEXIRI 2-PRODIGE 27)

Deregulation of the Cytoplasmic Tyrosine Kinase cSrc in the Absence of a Truncating Mutation at Codon 531 in Human Bladder Carcinoma

Prediction of Disease Outcome With Quantitative Measurement of HER-2 Receptor Expression and Dimerization in Patients With Breast Cancer

KRAS mutation testing in patients with metastatic colorectal carcinoma: An 18-month experience emphasizing the risk of false-negative results

Personalized Medicine by Analyzing Circulating DNA: Application to the Management Care of Colorectal Cancer Patients

P3.12 Circulating Dna Analysis in The Era of Personalized Cancer Medicine: Application to Kras/Braf Point Mutations Detection in Colorectal Cancer

Détection des mutations de KRAS : comparaison des résultats entre tissus fixés en formol/inclus en paraffine et tissus cryopréservés dans une série de 131 adénocarcinomes colorectaux

Suchergebnisse filtern